Anuh Pharma Ltd.

Financial

	Anuh Pharma	Shivalik Rasayan	Wanbury
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.0	n/a	n/a
Financials
5 yr Average ROE	15.87 %	7.33 %	-30.56 %
5yr average Equity Multiplier	1.62	1.84	-3.1
5yr Average Asset Turnover Ratio	1.35	0.47	1.51
5yr Avg Net Profit Margin	7.23 %	8.37 %	7.58 %
Price to Book	2.94	1.74	14.96
P/E	20.25	55.72	29.05
5yr Avg Cash Conversion Cycle	42.81 Days	79.22 Days	-119.82 Days
Inventory Days	50.87 Days	63.09 Days	20.62 Days
Days Receivable	111.12 Days	114.67 Days	49.78 Days
Days Payable	117.6 Days	157.87 Days	205.91 Days
5yr Average Interest Coverage Ratio	48.66	10.93	2.36
5yr Avg ROCE	21.17 %	9.58 %	-51.74 %
5yr Avg Operating Profit Margin	10.21 %	18.09 %	4.22 %
5 yr average Debt to Equity	0.02	0.16	-0.61
5yr CAGR Net Profit	10.73 %	-1.91 %	-2.79 %
5yr Average Return on Assets	9.84 %	3.97 %	11.1 %
Shareholdings
Promoter Holding	69.92 %	47.37 %	39.63 %
Share Pledged by Promoters	0.0	0.0	76.74 %
Change in Promoter Holding (3 Yrs)	-0.67 %	-2.95 %	-0.22 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Anuh Pharma	Shivalik Rasayan	Wanbury
Product Wise Break-Up	Product Wise Break-Up Bulk drug and Chemicals 100.0 ACTIVE PHARMA INGREDIENT 0 Pharma 0 Agrochemicals 0 API`s & Formulation 0	Product Wise Break-Up Pharmaceutical 43.36 Agro Chemicals 55.77 ACTIVE PHARMA INGREDIENT 0.87 Bulk drug and Chemicals 0 API`s & Formulation 0	Product Wise Break-Up Pharma 0 Agrochemicals 0 ACTIVE PHARMA INGREDIENT 0 Bulk drug and Chemicals 0 API`s & Formulation 0 Others 100
Location Wise Break-Up	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98	-	Location Wise Break-Up Rest of the World 0 India 38.09 Others 61.91
Brand Wise Break-Up	Brand Wise Break-Up Erythromycin 33.38 Cortico Steroids 15.41 Higher Macrolides 14.5 Sulphadoxine 13.6 Pyrazinamide 5.74 Chloramhenicol 4.98 Gliclazide 4.23 Ambroxol HCL 3.02 Others 5.14	-	-